These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11509687)

  • 1. Integrated end-stage renal disease care: the role of peritoneal dialysis.
    Blake PG
    Nephrol Dial Transplant; 2001; 16 Suppl 5():61-6. PubMed ID: 11509687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal dialysis or hemodialysis? A dilemma for the nephrologist.
    Shahab I; Khanna R; Nolph KD
    Adv Perit Dial; 2006; 22():180-5. PubMed ID: 16983966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
    De Vecchi AF; Dratwa M; Wiedemann ME
    Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
    Teerawattananon Y; Mugford M; Tangcharoensathien V
    Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
    Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care costs of peritoneal dialysis technique failure and dialysis modality switching.
    Chui BK; Manns B; Pannu N; Dong J; Wiebe N; Jindal K; Klarenbach SW
    Am J Kidney Dis; 2013 Jan; 61(1):104-11. PubMed ID: 22901772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing Landscape for Peritoneal Dialysis: Optimizing Utilization.
    Schreiber MJ
    Semin Dial; 2017 Mar; 30(2):149-157. PubMed ID: 28144977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
    Shih YC; Guo A; Just PM; Mujais S
    Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis versus peritoneal dialysis, which is cost-effective?
    Atapour A; Eshaghian A; Taheri D; Dolatkhah S
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):962-5. PubMed ID: 26354569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score.
    Chang YT; Hwang JS; Hung SY; Tsai MS; Wu JL; Sung JM; Wang JD
    Sci Rep; 2016 Jul; 6():30266. PubMed ID: 27461186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal dialysis: better than, equal to, or worse than hemodialysis? Data worth knowing before choosing a dialysis modality.
    Thodis E; Passadakis P; Vargemezis V; Oreopoulos DG
    Perit Dial Int; 2001; 21(1):25-35. PubMed ID: 11280493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of peritoneal dialysis as the first-line renal replacement modality.
    Van Biesen W; Vanholder R; Lameire N
    Perit Dial Int; 2000; 20(4):375-83. PubMed ID: 11007366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. For-profit versus not-for-profit dialysis care for children with end stage renal disease.
    Furth SL; Hwang W; Neu AM; Fivush BA; Powe NR
    Pediatrics; 1999 Sep; 104(3 Pt 1):519-24. PubMed ID: 10469779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of urgent-start peritoneal dialysis versus urgent-start hemodialysis in the United States.
    Liu FX; Ghaffari A; Dhatt H; Kumar V; Balsera C; Wallace E; Khairullah Q; Lesher B; Gao X; Henderson H; LaFleur P; Delgado EM; Alvarez MM; Hartley J; McClernon M; Walton S; Guest S
    Medicine (Baltimore); 2014 Dec; 93(28):e293. PubMed ID: 25526471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal dialysis should be considered as the first line of renal replacement therapy for most ESRD patients.
    Burkart JM
    Blood Purif; 2001; 19(2):179-84. PubMed ID: 11150806
    [No Abstract]   [Full Text] [Related]  

  • 20. Peritoneal dialysis compared with hemodialysis in the treatment of end-stage renal disease.
    Alloatti S; Manes M; Paternoster G; Gaiter AM; Molino A; Rosati C
    J Nephrol; 2000; 13(5):331-42. PubMed ID: 11063136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.